Auris Medical Holding AG Share Price Nasdaq
Equities
CH0408330303
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 24.16L 27.13L 23Cr |
---|---|---|---|---|---|
Net income 2024 * | -70L -78.62L -66Cr | Net income 2025 * | -1Cr -1.12Cr -94Cr | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.28
x | P/E ratio 2025 * |
-0.37
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.11% |
Latest transcript on Auris Medical Holding AG
Managers | Title | Age | Since |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/03/01 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01/21/01 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01/18/01 |
Mats Blom
BRD | Director/Board Member | 59 | 01/17/01 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/03/01 |
1st Jan change | Capi. | |
---|---|---|
+18.15% | 12TCr | |
+18.02% | 11TCr | |
+5.07% | 2.29TCr | |
-12.75% | 2.22TCr | |
-9.86% | 1.7TCr | |
-14.97% | 1.69TCr | |
-39.94% | 1.69TCr | |
+2.80% | 1.36TCr | |
+27.39% | 1.16TCr |